Marc van de Wetering

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 4

Top Topics

Neoadjuvant Chemotherapy

Top Venues

Science (New York, N.Y.)

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Lin Lin, Jeff DeMartino, Daisong Wang, Gijs J F van Son, Reinier van der Linden, Harry Begthel, Jeroen Korving, Amanda Andersson-Rolf, Stieneke van den Brink, Carmen Lopez-Iglesias, Willine J van de Wetering, Aleksandra Balwierz, Thanasis Margaritis, Marc van de Wetering, Peter J Peters, Jarno Drost, Johan H van Es, Hans Clevers
Unbiased transcription factor CRISPR screen identifies ZNF800 as master repressor of enteroendocrine differentiation. Science (New York, N.Y.) 382 (6669) (2023)
Lindy L Visser, Margit Bleijs, Thanasis Margaritis, Marc van de Wetering, Frank C P Holstege, Hans Clevers
Ewing sarcoma single-cell transcriptome analysis reveals functionally impaired antigen-presenting cells. Cancer research communications (2023)
Margit Bleijs, Corine Pleijte, Sem Engels, Femke Ringnalda, Friederike Meyer-Wentrup, Marc van de Wetering, Hans Clevers
EWSR1-WT1 Target Genes and Therapeutic Options Identified in a Novel DSRCT In Vitro Model. Cancers 13 (23) (2021)
Kamila Naxerova, Johannes G Reiter, Elena Brachtel, Jochen K Lennerz, Marc van de Wetering, Andrew Rowan, Tianxi Cai, Hans Clevers, Charles Swanton, Martin A Nowak, Stephen J Elledge, Rakesh K Jain
Origins of lymphatic and distant metastases in human colorectal cancer. Science (New York, N.Y.) 357 (6346) (2018)